Jim Wassil, CHIEF OPERATING OFFICER at Vaxcyte, Inc. (PCVX), sold 16,000 shares at $114.95 ($1.8M) on 2024-10-01, disclosed to the SEC on 2024-10-03.
Scheduled sale ($1.8M) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.42 | 2,312 | $262K | 14.3% |
| 2 | $113.42 | 2,312 | $262K | 14.3% |
| 3 | $114.32 | 3,349 | $383K | 20.9% |
| 4 | $114.32 | 3,349 | $383K | 20.9% |
| 5 | $114.95 | 2,339 | $269K | 14.7% |
| 6 | $114.95 | 2,339 |
| $269K |
| 14.7% |
| Total | $114.24 avg | 16,000 | $1.8M | 100% |
| Filing → |
| PCVX | SELL | 2026-09-02 | $212K | — | Filing → |
| PCVX | SELL | 2026-08-05 | $121K | — | Filing → |
| PCVX | SELL | 2026-07-06 | $127K | — | Filing → |